Sonderman had worked at GSW since 2001.
Nick Law, the global chief creative officer of R/GA, is leaving the company after 17 years to take on the newly created role of chief creative officer across Publicis Groupe and president of Publicis Communications.
She is overseeing three of the network's agencies in the newly created role.
The CEO of the independent healthcare agency discusses growing a business in digital in the early 2000s and the perks of remaining independent.
Sigurdsson is charged with leading the agency's digital offering to meet growing client demand.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.
WPP has named Karen Blackett as its first UK country manager, making her the most important agency leader in the British ad industry.
Celgene to buy Impact Biomedicines for up to $7 billion; Pfizer plans to cut 300 positions in neuroscience; Perrigo hires new CEO
Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.
The Department of Veteran Affairs issued an RFI at the end of November for a nationwide healthcare professional recruitment campaign.
The agency issue, people moves, and a series of restructures top the list.
VP of investor relations Teri Loxam will take over Ambrose's role in January.
Beiser previously held leadership roles at Edelman, Hilton, Discover, and Burson-Marsteller.
FDA approves first topical skin growth treatment; Teva to cut 14,000 jobs; Novartis Oncology CEO resigns
The VP of market access at Mitsubishi Tanabe Pharma America discusses driving access and bringing to market the first FDA-approved ALS drug in years.
The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."
GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.
Cannes Lions' longtime leader, chief spokesman, and a figure many viewed as the heart and soul of the global creativity festival will be moving on after the 2018 event ends.
DeVine will oversee the agency's health IT and medical device work.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.
The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial
W2O's Windy City office has added three health and analytics leaders over the past six months.
GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick
Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.
Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."
The blogger talks the challenges of influencer marketing in healthcare, chronic disease, and big brand activations.